Pfizer Group B strep vaccine for infants returns encouraging mid-stage trial resultsPfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.[Collection]

Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.https://www.cnbc.com/2023/07/19/pfizer-group-b-strep-vaccine-for-infants-returns-strong-trial-results.html